NCT01065961View on ClinicalTrials.gov

Randomized Controlled Trials of the Effects of Decadron on Swallowing, Airway, and Arthrodesis

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Swallowing
Interventions
DRUG

Decadron

Decadron will be given at a dose of 0.2 mg/kg intraoperatively, followed by Decadron 4 mg. every 6 hours for 24 hours.

DRUG

Saline

Placebo saline will be given intraoperatively as well as 4 doses every 6 hours for 24 hours.

Trial Locations (1)

12208

RECRUITING

Albany Medical Center, Albany

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER